Zurich Cantonal Bank
OCUL icon

Zurich Cantonal Bank’s Ocular Therapeutix OCUL Stock Holding History

Zurich Cantonal Bank’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Hold
36,056
– – ﹤0.01% 2116
2026
Q1 		$305K Hold
36,056
– – ﹤0.01% 2083
2025
Q4 		$438K Buy
36,056
+14,641
+68% +$178K ﹤0.01% 1862
2025
Q3 		$250K Hold
21,415
– – ﹤0.01% 2086
2025
Q2 		$199K Sell
21,415
-10,324
-33% -$80.8K ﹤0.01% 2141
2025
Q1 		$233K Sell
31,739
-3,002
-9% -$23.1K ﹤0.01% 2018
2024
Q4 		$297K Buy
34,741
+2,760
+9% +$26.9K ﹤0.01% 1947
2024
Q3 		$278K Sell
31,981
-63
-0.2% -$519 ﹤0.01% 1926
2024
Q2 		$219K Buy
32,044
+28,309
+758% +$175K ﹤0.01% 1990
2024
Q1 		$34K Buy
+3,735
New +$26.5K ﹤0.01% 2601
2022
Q2 		– Sell
-8,044
Closed -$40K – 2919
2022
Q1 		$40K Sell
8,044
-2,614
-25% -$14.5K ﹤0.01% 2572
2021
Q4 		$74K Sell
10,658
-271
-2% -$2.1K ﹤0.01% 2619
2021
Q3 		$109K Buy
10,929
+11
+0.1% +$124 ﹤0.01% 2294
2021
Q2 		$155K Buy
10,918
+253
+2% +$3.85K ﹤0.01% 1978
2021
Q1 		$175K Buy
10,665
+727
+7% +$14K ﹤0.01% 1855
2020
Q4 		$206K Buy
+9,938
New +$148K ﹤0.01% 1821

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Zurich Cantonal Bank's OCUL Position: Q2 2026 in Review

Zurich Cantonal Bank held its Ocular Therapeutix (OCUL) position steady in Q2 2026 at 36,056 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #2116.

Zurich Cantonal Bank first reported a position in OCUL in Q4 2020 and has held it in 16 quarters since. The position peaked at $438K in Q4 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Zurich Cantonal Bank held 36,056 shares of Ocular Therapeutix worth $354K as of Q2 2026.
  • Zurich Cantonal Bank left its Ocular Therapeutix share count unchanged in Q2 2026.
  • Ocular Therapeutix made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2116 holding.
  • Zurich Cantonal Bank first reported a position in Ocular Therapeutix in Q4 2020 and has held it in 16 quarters since.
  • Zurich Cantonal Bank's Ocular Therapeutix position peaked at $438K in Q4 2025.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.